ESG

With FDA alignment for its pivotal Phase 3 trial, Oncolytics Biotech is poised to bring the first immunotherapy to the challenging pancreatic cancer landscape.

A C$1M private placement for CHAR Technologies signals strong investor faith in its waste-to-energy tech, promising to decarbonize heavy industry.

Canada Post's 2026 stamp lineup is more than a collection; it's a strategic investment in public health, reconciliation, and community wellness.

Amid a major corporate overhaul, Emergent BioSolutions secures a key FDA approval, signaling a new era for the firm and for U.S. biodefense strategy.

A positive EU opinion for Sobi's Aspaveli could bring the first-ever targeted treatment for two rare kidney diseases, shaking up a market desperate for innovation.

A Chinese eco-tech firm is betting on India's infrastructure boom. Can its waste-to-value solutions capture a piece of this massive, competitive market?

Fresh off its IPO, iOThree is pushing AI and certified digital tools. Can its innovation engine and Asian expansion overcome market headwinds?

A new car wash opening reveals a blueprint for modern industry disruption, blending aggressive growth, tech-driven efficiency, and savvy community strategy.

A junior miner is fast-tracking gold and critical metals production in Québec by reviving a key mill. Is this a strategic supply chain win or just savvy promotion?

Acadia's new powder form of the only Rett syndrome drug offers families vital choice, easing daily care and showing the power of patient-led innovation.

A new nonprofit telehealth platform for men is launching, but its true innovation may lie in its ambitious blend of holistic care and community support.

A new AI-powered diagnostic test provides unprecedented clarity for millions at risk of esophageal cancer, challenging the old 'watch and wait' model.

As logistics giant Ryder plans a seamless CEO shift from Sanchez to insider John Diez, we analyze the strategy of continuity in a volatile market.

Creekstone Energy plans to add 2 gigawatts of nuclear power to its Utah Gigasite, a bold move to satisfy AI's insatiable energy appetite.

Bunker Hill Mining is pairing a strategic land grab with AI-driven exploration, a dual-pronged strategy aiming to revitalize a legendary American mining district.

With over 123 million displaced, refugee camps are now de facto cities. Temporary water solutions are fueling disease, making the case for permanent fixes.

The restaurant giant unveils a massive capital return plan, promising 100% of future free cash flow to investors while funding aggressive expansion in China.

atNorth's award-winning ICE03 facility isn't just a data center; it's a holistic model integrating green tech, circular economies, and community growth.

As Uxin prepares to report Q3 results, all eyes are on its ambitious superstore strategy and whether it can drive profitability in a complex market.

Genmab's $8 billion acquisition of Merus isn't just a deal; it's a bold strategy to own its destiny and dominate the future of oncology therapeutics.